Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IM Ketamine vs Midazolam for Suicidal ER Patients
NCT04640636Phase 4Suspended
- Sponsor
- New York State Psychiatric Institute
- Start
- Feb 2021
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketamine in suicidal ideation (2 arms), sponsored by New York State Psychiatric Institute. Primary endpoint: Scale for Suicidal Ideation at 24 hours. Started Feb 2021; status: suspended.
02
Drugs
ketamine
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT04640636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04640636.